Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibition

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1949-52.
No abstract available

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Deaminase Inhibitors*
  • Adult
  • Coformycin* / analogs & derivatives
  • Coformycin* / therapeutic use
  • Deoxyadenine Nucleotides / blood
  • Deoxyadenosines / blood
  • Humans
  • In Vitro Techniques
  • Leukemia, Lymphoid / blood
  • Leukemia, Lymphoid / drug therapy*
  • Male
  • Nucleoside Deaminases / antagonists & inhibitors*
  • Ribonucleosides* / analogs & derivatives

Substances

  • Adenosine Deaminase Inhibitors
  • Deoxyadenine Nucleotides
  • Deoxyadenosines
  • Ribonucleosides
  • Coformycin
  • Nucleoside Deaminases